BioNTech CEO Uğur Şahin disposes of $3,304,076 in common shares

• BioNTech CEO Ugur Sahin sold 34,000 ordinary shares on Oct. 1-2, according to a Form 4 filing.
• Sales priced at USD 97.4556 on Oct. 1, USD 96.7249 on Oct. 2.
• Directly held ordinary shares fell to 180,209 following the transactions.
• Filing also lists 39,218,111 ordinary shares held indirectly.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioNTech SE published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002123975-26-000029), on October 02, 2026, and is solely responsible for the information contained therein.